Literature DB >> 11207787

Surgical outcome of corpus callosotomy in patients with drop attacks.

T Maehara1, H Shimizu.   

Abstract

PURPOSE: We examined presurgical factors that independently influence surgical outcome after corpus callosotomy. For adequate measurement of the surgical outcome, we analyzed seizure outcome of drop attacks, postoperative overall daily function, and family satisfaction.
METHODS: At least 2 years after callosotomy (mean, 40.0 months), we retrospectively investigated 52 patients with drop attacks. As presurgical factors, we analyzed the age at surgery, age at seizure onset, age at drop attack onset, sex, hemiparesis, severe mental retardation, EEG abnormality, MRI abnormality, and extent of callosal section (total or partial callosotomy). Stepwise logistic regression was used for analysis.
RESULTS: Satisfactory outcome (seizure cessation or >90% seizure reduction) was achieved in 85% of patients with drop attacks, 32% of those with generalized tonic seizures, and 31% of those with generalized tonic-clonic seizures. The families assessed the overall daily function as improved in 62% of patients, unchanged in 23%, and impaired in 15%. Family satisfaction with callosotomy was achieved in 83% of patients (definitely satisfied, 39%, somewhat satisfied, 44%). Total callosotomy is independently predictive of satisfactory reduction of drop attacks (p = 0.013). A younger age is independently predictive of improvement of overall daily function (impaired and improved: p = 0.004) and family satisfaction (unsatisfied and somewhat satisfied, p = 0.018; unsatisfied and definitely satisfied, p = 0.0006).
CONCLUSIONS: In the present study, we found that total callosotomy is more effective for treatment of drop attacks than partial callosotomy and that children receive more benefit than adults after callosotomy.

Entities:  

Mesh:

Year:  2001        PMID: 11207787     DOI: 10.1046/j.1528-1157.2001.081422.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  29 in total

Review 1.  Corpus callosotomy in children and the disconnection syndromes: a review.

Authors:  Andrew Jea; Shobhan Vachhrajani; Elysa Widjaja; Daniel Nilsson; Charles Raybaud; Manohar Shroff; James T Rutka
Journal:  Childs Nerv Syst       Date:  2008-03-29       Impact factor: 1.475

2.  When should corpus callosotomy be offered as palliative therapy?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-01       Impact factor: 7.500

Review 3.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 4.  Pediatric epilepsy surgery.

Authors:  Anuj Jayakar; Jeffrey Bolton
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 5.  Rates and predictors of seizure outcome after corpus callosotomy for drug-resistant epilepsy: a meta-analysis.

Authors:  Alvin Y Chan; John D Rolston; Brian Lee; Sumeet Vadera; Dario J Englot
Journal:  J Neurosurg       Date:  2018-05-01       Impact factor: 5.115

6.  Corpus callosotomy in children.

Authors:  Tai-Tong Wong; Shang-Yeong Kwan; Kai-Ping Chang; Wu Hsiu-Mei; Tsui-Fen Yang; Ying-Sheue Chen; Lee Yi-Yen
Journal:  Childs Nerv Syst       Date:  2006-07-08       Impact factor: 1.475

7.  Corpus Callosotomy for Intractable Epilepsy Revisited: The Children's Hospital of Michigan Series.

Authors:  Aimee F Luat; Eishi Asano; Ajay Kumar; Harry T Chugani; Sandeep Sood
Journal:  J Child Neurol       Date:  2017-03-08       Impact factor: 1.987

Review 8.  Falls, faints, fits and funny turns.

Authors:  Roland D Thijs; Bastiaan R Bloem; J Gert van Dijk
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

9.  New treatment options for lennox-gastaut syndrome.

Authors:  Monica E Lemmon; Eric H Kossoff
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 10.  Seizure outcomes in nonresective epilepsy surgery: an update.

Authors:  Dario J Englot; Harjus Birk; Edward F Chang
Journal:  Neurosurg Rev       Date:  2016-05-21       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.